Baxter Healthcare recall: Pro+ MRS Surface for Versacare and 2 more products
Baxter Healthcare Corporation is recalling Pro+ MRS Surface for Versacare and 2 more products – 169 units; 824 units; 6 units. The U.S. Food and Drug Administration published the recall on September 30, 2026; it began on August 18, 2026. Distributed nationwide.
Serious Class II means the product may cause temporary or medically reversible health problems, or the chance of serious harm is remote.
Share
| Product | Pro+ MRS Surface for Versacare and 2 more products |
| Brand | Baxter Healthcare |
| Company | Baxter Healthcare Corporation |
| Type | Medical devices |
| Classification | Class II |
| Recall date | August 18, 2026 |
| Published by FDA | September 30, 2026 |
| Quantity | 169 units; 824 units; 6 units |
| Recall ID | 99606 |
Recalled products (3)
- PRO+ MRS SURFACE FOR VERSACARE, mattress with Advanced Microclimate Technology (AMT) uses a non-powered system of intake and output valves to provide weight-based pressure redistribution whenever a patient moves or is repositioned, Model/Catalog Number: P3255A08
- FDA recall number
- Z-3262-2026
- Codes, lots and dates
- Serial Number: A171BP3769 - B057BP6765 UDI-DI Number: 00887761007543
- Quantity
- 169 units
- Classification
- Class II
- PRO+ 36" MRS SURFACE, mattress with Advanced Microclimate Technology (AMT) uses a non-powered system of intake and output valves to provide weight-based pressure redistribution whenever a patient moves or is repositioned, Model/Catalog Number: P7924A13
- FDA recall number
- Z-3263-2026
- Codes, lots and dates
- Serial Number: A136BP2433 - B052BP6510 UDI-DI Number: 00887761007659
- Quantity
- 824 units
- Classification
- Class II
- PRO+ 40" MRS SURFACE, mattress with Advanced Microclimate Technology (AMT) uses a non-powered system of intake and output valves to provide weight-based pressure redistribution whenever a patient moves or is repositioned, Model/Catalog Number: P7924A14
- FDA recall number
- Z-3264-2026
- Codes, lots and dates
- Serial Number: A305BP8842 - A305BP8847 UDI-DI Number: 00887761007666
- Quantity
- 6 units
- Classification
- Class II
Identifiers and details
- FDA event ID
- 99606
- Initiated
- Voluntary: Firm initiated
- Status
- Ongoing
- Firm location
- Deerfield, IL, United States
Why it was recalled
The reason the FDA lists: “There is an error in the product description on the Unique Device Identification (UDI) label. These discrepancies in labeling do not align with the approved product or product specifications and may lead to incorrect product identification or selection, potentially resulting in use with an incompatible bed frame.”
Where it was sold
Nationwide. Distribution as the FDA records it: “Worldwide distribution - US Nationwide and the country of Canada.”
What to do
Compare the recall numbers, lot numbers and expiration dates with what you have. Do not stop a prescribed medicine or device without talking to your pharmacist or doctor – they can arrange a replacement from an unaffected lot.
Official notice: FDA Enforcement Report record (event 99606, openFDA) – the same recall numbers can be searched in the FDA Enforcement Report.
Other Baxter Healthcare recalls
| Date | Recall | Problem | Agency |
|---|---|---|---|
| Sep 30, 2026 |  Baxter Healthcare recall: Volara, HC, Na aMedical devices · 2 | Contamination within the release test equipment flow path could have affected the accuracy… Serious | FDA Class II |
| Sep 16, 2026 |  Baxter Healthcare recall: Dextrose InjectionDrugs · 606 bags | Presence of Particulate Matter: particulate matter identified as stainless steel particles… Most serious | FDA Class I |
| Sep 9, 2026 | Baxter Healthcare recall: 0.9% Sodium Chloride Injection USPDrugs · 145,464 500mL bags | Presence of particulate matter: Particulates identified as fiberglass Most serious | FDA Class I |
| Sep 9, 2026 | Baxter Healthcare recall: Baxter Novum IQ Syringe PumpMedical devices · 14601 units; 4 units | A software issue that may occur during a Volume/Time (VOT) multi-syringe infusion when a s… Serious | FDA Class II |
| Sep 9, 2026 | Baxter Healthcare recall: Vancomycin Injection and 10 more productsDrugs · N/A | manufacturing-practice violations Serious | FDA Class II |
| Aug 19, 2026 | Baxter Healthcare recall: Baxter Duo-Vent Solution Set and Male Luer Lock AdapterMedical devices · 24528 units | Baxter received customer reports of air bubbles in the drip chamber and tubing when a pres… Most serious | FDA Class I |
| Aug 19, 2026 | Baxter Healthcare recall: Cefazolin in DextroseDrugs · 19,032 bags | Presence of Particulate Matter Most serious | FDA Class I |
All 8 Baxter Healthcare recalls →
About this recall
Is Baxter Healthcare Pro+ MRS Surface for Versacare recalled?
Yes. Baxter Healthcare Corporation recalled it on August 18, 2026; FDA published it September 30, 2026 (Class II). Only the lots, dates or models listed on this page are included.
Why was it recalled?
There is an error in the product description on the Unique Device Identification (UDI) label. These discrepancies in labeling do not align with the approved product or product specifications and may lead to incorrect product identification or selection, potentially resulting in use with an incompatible bed frame.
What should I do if I have it?
Compare the recall numbers, lot numbers and expiration dates with what you have. Do not stop a prescribed medicine or device without talking to your pharmacist or doctor – they can arrange a replacement from an unaffected lot.
Where was it sold?
Nationwide.
More recalls
Source: recall records published by the U.S. Food and Drug Administration (openFDA Enforcement Reports), the USDA Food Safety and Inspection Service, the Consumer Product Safety Commission and the National Highway Traffic Safety Administration, collected twice a day. Product names, lot codes, dates and model numbers are shown exactly as the agency lists them; the agency's notice is the authority. 77.today is not affiliated with any of these agencies.